bioRxiv Science⌕ Search

Biology subjects

Mulvihill, D. P.

Publications and source records attributed to Mulvihill, D. P..

7 recordsLinked to original sources

Peptide-Induced Formation of Extracellular Vesicles that are DistinctFrom Endogenous E. coli OMVs, and Provide an Enhanced Platformfor Protein Production and Purification.

Bacterial outer membrane vesicles (OMVs), are nano-sized, spherical structures released by Gram-negative bacteria that play diverse roles in bacterial physiology, including communication, nutrient acquisition, and host interactions. These vesicles bud from the bacterial outer membrane and contain lipopolysaccharides, periplasmic proteins, nucleotides, and other biomolecules. The Vesicle Nucleating peptide (VNp) is a short peptide tag that, when fused to the amino terminus of a protein of interest, promotes the formation of bespoke recombinant extracellular vesicles in Escherichia coli, enabling efficient production and simplified purification of recombinant proteins. Here, we characterise VNp-induced vesicles and compare their composition and organisation with naturally produced E. coli OMVs. While both vesicle types possess a single outer membrane-derived lipid bilayer, recombinant protein is highly enriched within the VNp vesicles compared to endogenous OMVs. VNp-fusions and periplasm-targeted recombinant proteins localize to distinct vesicle populations, with VNp-fusions showing markedly higher intra-vesicular concentrations and vesicular purity, compared to the OMV targeted protein. OmpX co-expression further enriched the VNp-fusion content of vesicles, further enhancing yield. The VNp-vesicle lumen is an oxidizing environment, thus supports formation of inter- and intra-molecular disulfide bonds within encapsulated proteins. Overall, VNp-induced vesicles represent a distinct class of recombinant extracellular vesicles that offer a simple and efficient route for producing and purifying concentrated, correctly folded recombinant proteins, expanding the utility of bacterial vesicle systems for biotechnological applications. Significance StatementBacterial extracellular vesicles are recognized as versatile tools for biotechnology yet engineering bacterial vesicle production in a controlled and efficient manner remains challenging. Here we describe how a short Vesicle Nucleating Peptide (VNp) tag, fused to a protein of interest, that can be used to program Escherichia coli to produce recombinant extracellular vesicles that are compositionally and structurally distinct from natural bacterial outer membrane vesicles (OMVs). VNp-induced vesicles are more homogeneous, and more highly enriched in target fusion proteins, providing a simple and efficient route for protein production and purification. The oxidizing lumen of these vesicles supports disulfide bond formation, and rapid compartmentalisation enables expression of otherwise challenging or toxic proteins. This work characterises a distinct class of recombinant bacterial vesicles and establishes a practical platform for producing correctly folded, concentrated, partially purified proteins in a self-packaged form, expanding the potential applications of bacterial extracellular vesicles in biotechnology and synthetic biology.

bioengineering↗

A High-Throughput Multiwell-Plate based Approach for the combined Expression, Export and Assay of Recombinant Proteins.

High-throughput screening (HTS) of proteins has a wide range of applications across the biology, biotechnology, and medicine disciplines. These include yield optimisation, drug or biomarker discovery, and protein engineering, among others. Factors that need to be considered in designing high throughput protein expression and screening methods, be that for expression, activity, stability, or binding as says, include the required yield, reproducibility, solubility, stability, purity and activity of the protein. Thus, larger culture volumes and time-consuming manual protein extraction and purification steps are normally required to produce sufficient quantity of protein of appropriate purity. This limits the type of assay, and number of protein variants that can be simultaneously tested in an experiment. Here we describe a HTS protocol that allows the overnight expression, export and assay of recombinant proteins from E. coli cells in the same multi-well plate tube. The protocol uses a recently described Vesicle Nucleating peptide (VNp) technology that promotes high yield vesicular export of functional proteins from E. coli into the culture media. The resulting protein is of sufficient purity and yield that in can be used directly in plate-based enzymatic assays without additional purification. This simple single plate protocol allows itself to a wide range of high-throughput research and development screening applications, ranging from streamlining protein production and identification of activity enhancing mutations, to ligand screening for basic research, biotechnological and drug discovery applications.

molecular biology↗

Simple recombinant monoclonal antibody production from E. coli.

AO_SCPLOWBSTRACTC_SCPLOWAntibodies are valuable biological reagents used in a wide range of discovery research, biotechnology, diagnostic and therapeutic applications. Currently both commercial and lab scale antibody production is reliant on expression from mammalian cells, which can be time consuming and requires use of specialist facilities and costly growth reagents. Here we describe a simple, rapid and cheap method for producing and isolating functional monoclonal antibodies and antibody fragments from bacterial cells that can be used in a range of laboratory applications. This simple method only requires access to basic microbial cell culture and molecular biology equipment, making scalable in-house antibody production accessible to the global diagnostics, therapeutics and molecular bioscience research communities.

molecular biology↗

Optimised protocol for production and analysis of recombinant protein-filled vesicles from E. coli.

We have developed an innovative system that exports diverse recombinant proteins in membrane bound vesicles from E. coli 1. These recombinant vesicles compartmentalise proteins within a micro-environment that enables production of otherwise challenging insoluble, toxic, or disulphide-bond containing proteins from bacteria. The release of vesicle-packaged proteins supports isolation from the culture and allows long-term storage of active protein. This technology results in high yields of vesicle-packaged, functional proteins for efficient downstream processing for a wide range of applications from discovery science to applied biotechnology and medicine. In this article, and associated video, we provide a detailed protocol of the method, and highlight key steps in the methodology to maximise recombinant protein filled vesicle production. SummaryThis protocol describes a detailed method for the bacterial production of recombinant proteins, including typically insoluble or disulphide-bond containing proteins, packaged inside extracellular membrane-bound vesicles. This has the potential to applied to many areas of scientific research including applied biotechnology and medicine.

molecular biology↗

Exceptional yield vesicle packaged recombinant protein production from E. coli.

We describe a novel system that exports diverse recombinant proteins in extracellular vesicles from E. coli. The vesicles not only compartmentalise toxic, insoluble and disulphide bond containing proteins in a soluble and functional form (e.g. DNaseI, nanobodies and IgG-fusions), but the continued release of the inducible vesicle packaged proteins into the media supports continuous isolation of protein from active culture within a micro-environment allowing stable long-term storage. This technology results in unprecedented yields of vesicle packaged functional proteins for efficient downstream processing for a wide range of applications from discovery science to applied biotechnology and medicine.

molecular biology↗

Cardiac contraction velocity has evolved to match heart rate with body size through variation in β-cardiac myosin sequence.

Heart rate and the maximum velocity of contraction of striated muscle are inversely related to species size. As mammals evolve to different sizes, adaptations are required such as slower contracting heart and skeletal muscles. Analysis of the motor domain of {beta}-myosin from 67 mammals from two clades identifies 14 sites, out of 800, strongly associated with body mass (p<0.01) but not with the clade (p>0.05). Nine of these sites were mutated in the human {beta}-myosin to make it resemble the rat sequence. Biochemical analysis revealed that the rat-human {beta}-myosin chimera functioned like the native rat myosin with a two fold increase in both motility and in the rate of ADP release from the actin.myosin cross-bridge (the step that limits contraction velocity). Both clades use the same small set of amino acids to adjust contraction velocity, suggesting a limited number of ways in which velocity can be manipulated.

biochemistry↗

TorC2 dependent phosphorylation modulates calcium regulation of fission yeast myosin.

All cells have the ability to respond to changes in their environment. Signalling networks modulate cytoskeleton and membrane organisation to impact cell cycle progression, polarised cell growth and multicellular development according to the environmental setting. Using diverse in vitro, in vivo and single molecule techniques we have explored the role of myosin-1 signalling in regulating endocytosis during both mitotic and meiotic cell cycles. We have established that a conserved serine within the neck region of the sole fission yeast myosin-1 is phosphorylated in a TORC2 dependent manner to modulate myosin function. Myo1 neck phosphorylation brings about a change in the conformation of the neck region and modifies its interaction with calmodulins, Myo1 dynamics at endocytic foci, and promotes calcium dependent switching between different calmodulin light chains. These data provide insight into a novel mechanism by which myosin neck phosphorylation modulates acto-myosin dynamics to control polarised cell growth in response to mitotic and meiotic cell-cycle progression and the cellular environment.

cell biology↗